Inflammation and accelerated atherosclerosis: Basic mechanisms

被引:64
作者
Doria, A
Sherer, Y
Meroni, PL
Shoenfeld, Y [1 ]
机构
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Sackler Fac Med, Dept Med B,Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[2] Univ Padua, Dept Med & Surg Sci, Div Rheumatol, I-35128 Padua, Italy
[3] Univ Milan, IRCCS, Ist Auxol Italiano, Dept Internal Med,Allergy & Clin Immunol Unit, I-10249 Milan, Italy
关键词
D O I
10.1016/j.rdc.2005.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article summarizes knowledge of the pathogenic mechanisms in autoimmune rheumatic diseases as risk factors for accelerated atherosclerosis. The studies described support a role for immunologic-inflammatory mechanisms in the pathogenesis of atherosclerosis. This immunologic-inflammatory state is evident in many autoimmune diseases, but also in the general population lacking an overt autoimmune disease. The ability to immunomodulate atherosclerosis (currently only experimental) should lead to future research into the mechanisms and treatment of atherosclerosis, the leading cause of death in the Western world.
引用
收藏
页码:355 / +
页数:9
相关论文
共 44 条
[1]   Complement and complement regulatory proteins as potential molecular targets for vascular diseases [J].
Acosta, J ;
Qin, SB ;
Halperin, J .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (02) :203-211
[2]   Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice [J].
Afek, A ;
George, J ;
Shoenfeld, Y ;
Gilburd, B ;
Levy, Y ;
Shaish, A ;
Keren, P ;
Janackovic, Z ;
Goldberg, I ;
Kopolovic, J ;
Harats, D .
PATHOBIOLOGY, 1999, 67 (01) :19-25
[3]   PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL [J].
BERGMARK, C ;
WU, R ;
DEFAIRE, U ;
LEFVERT, AK ;
SWEDENBORG, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) :441-445
[4]   Endothelial dysfunction - A marker of atherosclerotic risk [J].
Bonetti, PO ;
Lerman, LO ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :168-175
[5]  
Cines DB, 1998, BLOOD, V91, P3527
[6]  
Emeson EE, 1996, AM J PATHOL, V149, P675
[7]   Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies [J].
Farsi, A ;
Domeneghetti, MP ;
Brunelli, T ;
Gori, AM ;
Fedi, S ;
Gensini, GF ;
Giglioli, C ;
Prisco, D ;
Passaleva, A ;
Meroni, PL ;
Del Papa, N ;
Abbate, R .
ATHEROSCLEROSIS, 2001, 154 (02) :429-436
[8]   Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts [J].
Faulk, WP ;
Rose, M ;
Meroni, PL ;
Del Papa, N ;
Torry, RJ ;
Labarrere, CA ;
Busing, K ;
Crisp, SJ ;
Dunn, MJ ;
Nelson, DR .
HUMAN IMMUNOLOGY, 1999, 60 (09) :826-832
[9]  
George J, 2000, CIRCULATION, V102, P1822
[10]   Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies [J].
George, J ;
Afek, A ;
Gilburd, B ;
Levy, Y ;
Blank, M ;
Kopolovic, J ;
Harats, D ;
Shoenfeld, Y .
LUPUS, 1997, 6 (09) :723-729